Gene · 10211
Papers2,417
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,417
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Virus-Host Protein Interaction Network of the Hepatitis E Virus ORF2-4 by Mammalian Two-Hybrid Assays. | Viruses | 2023 | 38140653 | PubTator, text mining | PubMed |
| Viral Components Trafficking with(in) Extracellular Vesicles. | Viruses | 2023 | 38140574 | PubTator, text mining | PubMed |
| p140Cap modulates the mevalonate pathway decreasing cell migration and enhancing drug sensitivity in breast cancer cells. | Cell Death Dis | 2023 | 38123597 | PubTator, text mining | PubMed |
| [Tandem mass tag-based quantitative proteomics analysis of plasma and plasma exosomes in Parkinson's disease]. | Se Pu | 2023 | 38093537 | PubTator, text mining | PubMed |
| Are There Lipid Membrane-Domain Subtypes in Neurons with Different Roles in Calcium Signaling? | Molecules | 2023 | 38067638 | PubTator, text mining | PubMed |
| Stem cell-derived small extracellular vesicles embedded into methacrylated hyaluronic acid wound dressings accelerate wound repair in a pressure model of diabetic ulcer. | J Nanobiotechnology | 2023 | 38062461 | PubTator, text mining | PubMed |
| A clinically relevant large-scale biomanufacturing workflow to produce natural killer cells and natural killer cell-derived extracellular vesicles for cancer immunotherapy. | J Extracell Vesicles | 2023 | 38054534 | PubTator, text mining | PubMed |
| Differential roles of eNOS in late effects of VEGF-A on hyperpermeability in different types of endothelial cells. | Sci Rep | 2023 | 38052807 | PubTator, text mining | PubMed |
| Multilevel omics for the discovery of biomarkers in pediatric sepsis. | Pediatr Investig | 2023 | 38050541 | PubTator, text mining | PubMed |
| Effective cell membrane tension protects red blood cells against malaria invasion. | PLoS Comput Biol | 2023 | 38048346 | PubTator, text mining | PubMed |
| Circulating plasma miR-23b-3p as a biomarker target for idiopathic Parkinson's disease: comparison with small extracellular vesicle miRNA. | Front Neurosci | 2023 | 38033547 | PubTator, text mining | PubMed |
| A1BG-AS1 promotes adriamycin resistance of breast cancer by recruiting IGF2BP2 to upregulate ABCB1 in an m6A-dependent manner. | Sci Rep | 2023 | 38007504 | PubTator, text mining | PubMed |
| MiR-506 Promotes Antitumor Immune Response in Pancreatic Cancer by Reprogramming Tumor-Associated Macrophages toward an M1 Phenotype. | Biomedicines | 2023 | 38001876 | PubTator, text mining | PubMed |
| Transcriptomic landscape based on annotated clinical features reveals PLPP2 involvement in lipid raft-mediated proliferation signature of early-stage lung adenocarcinoma. | J Exp Clin Cancer Res | 2023 | 37996944 | PubTator, text mining | PubMed |
| Jagged1 contained in MSC-derived small extracellular vesicles promotes squamous differentiation of cervical cancer by activating NOTCH pathway. | J Cancer Res Clin Oncol | 2023 | 37994984 | PubTator, text mining | PubMed |
| Tumor-derived exosomal linc00881 induces lung fibroblast activation and promotes osteosarcoma lung migration. | Cancer Cell Int | 2023 | 37990331 | PubTator, text mining | PubMed |
| Baseline extracellular vesicle miRNA-30c and autophagic CTCs predict chemoradiotherapy resistance and outcomes in patients with lung cancer. | Biomark Res | 2023 | 37968730 | PubTator, text mining | PubMed |
| HIV-1 Nef Changes the Proteome of T Cells Extracellular Vesicles Depleting IFITMs and Other Antiviral Factors. | Mol Cell Proteomics | 2023 | 37940003 | PubTator, text mining | PubMed |
| EMP3 sustains oncogenic EGFR/CDK2 signaling by restricting receptor degradation in glioblastoma. | Acta Neuropathol Commun | 2023 | 37936247 | PubTator, text mining | PubMed |
| RTP801 mediates transneuronal toxicity in culture via extracellular vesicles. | J Extracell Vesicles | 2023 | 37932242 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10211/papers?page=8